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Abstract 
Background: Allergies are a serious public health issue and prevalences are rising worldwide. The 
role of antibiotics in the development of allergies has repeatedly been discussed, as results remain 
inconsistent.  
The aim of this study was to investigate the association between pre- & postnatal antibiotic exposure 
and subsequent development of allergies (atopic dermatitis, food allergy, asthma, atopic sensitization 
and allergic rhinitis). 
 
Methods: A total of 1080 children who participated in a European birth cohort study (PASTURE) 
were included in this analysis. Data on antibiotic exposure during pregnancy and/or first year of life 
and allergic diseases were collected by questionnaires from pregnancy up to 6 years of age and 
analysed by performing logistic regressions. To take into account reverse causation, we included 
models, where children with diagnosis or symptoms of the respective disease in the first year of life 
were excluded.  
 
Results: Antibiotic exposure in utero was significantly and positively associated with atopic 
dermatitis and food allergy. The strongest effect was on diseases with onset within the first year of life 
(for atopic dermatitis: aOR 1.66, 95% CI 1.11–2.48; and for food allergy: aOR 3.01, 95% CI 1.22-
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7.47). Antibiotics in the first year of life were positively associated with atopic dermatitis up to 4 
years (aOR 2.73, 95% CI 1.66-4.49), and also suggest a dose-response relationship. A tendency was 
observed with asthma between 3 & 6 years (aOR 1.65, 95% CI 0.95-2.86).  
 
Conclusions: Our findings show positive associations between exposure to antibiotics and allergies, 
mainly with atopic dermatitis and food allergy within the first year of life, after prenatal exposure and, 
atopic dermatitis and asthma after postnatal exposure to antibiotics in children born in rural settings.  
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allergy; antibiotics; children; atopic dermatitis; food allergy; asthma 
 
Abbreviations used  
aOR: Adjusted odds ratio  
CI: Confidence interval 
ISCED: International Standard Classification of Education 
OR: Odds ratio 
PASTURE: Protection against Allergy-Study in Rural Environments  
SCORAD: Scoring atopic dermatitis 
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Introduction  
A rise in the prevalence of allergic diseases has been observed worldwide over the last decades. 
Primary prevention remains a challenge, as the reasons for development of allergies are still 
incompletely understood.1 
A trend for an increased antibiotic use paralleling the epidemics of asthma has been observed.2 
Therefore, a potential role of antibiotics in the development of allergic diseases has been discussed. 
Three biological mechanisms were suggested that support the link between antibiotics and allergy. 
Firstly, antibiotics change the course of infection, which may cause the immune system to shift 
towards an allergic pathway.2 Secondly, experimental studies showed that certain types of antibiotics 
suppress mediators of the Th1 response, which might lead to a deviation towards the Th2 response 
and therefore promote the development of allergy.3 Lastly, animal studies have shown that perinatal 
exposure to vancomycin impacts the gut microbiome, which subsequently increases the susceptibility 
to asthma.4 
 
However, in spite of numerous studies on this subject, the results remain inconsistent.  
It has been discussed that such analysis is very susceptible to confounding, as well as reverse 
causation.2,5,6 
 
Data from the PASTURE birth cohort, prospectively collected, allows us to study the relationship 
between prenatal and postnatal exposures and the development of allergic diseases.7 Here, the 
objective was to study the relationship between antibiotic use during pregnancy or the first year of life 
and the development of allergic diseases.  
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Methods  
Study design and population  
The PASTURE study is a prospective birth cohort including children living in rural areas of five 
European countries (Austria, Finland, France, Germany and Switzerland). The design of this cohort 
has been described in detail elsewhere.7 Overall, 1133 children were included in this study. 
Questionnaires were based on previous studies.8-10 They were administered in interviews or self-
administered to the mothers. Children with data available on antibiotic exposure in utero (n=1080) or 
in the first year of life (n=1019) were included in these analyses.  
 
Definitions 
Data on antibiotic exposure during pregnancy (“ever use of antibiotics”) was obtained from 
questionnaires which were administered in the third trimester of pregnancy and when the child was 2 
months old. Information on antibiotic exposure during the first year of life including information on 
indication (bronchitis/pneumonia vs. other) was obtained from the 2-month (“ever use of antibiotics”) 
and 12-month (“use of antibiotics since last visit”) questionnaires. Data on allergic symptoms and 
doctor-diagnosis of allergic diseases was obtained from questionnaires at the age of 12, 18 and 24 
months and then yearly up to 6 years of age.  
Atopic dermatitis was defined as reported doctor-diagnosis up to 6 years of age and/or diagnosis made 
during the medical examination at 1 year of age (all these children had a positive SCORAD score 
(>0)). We also used the point prevalence of atopic dermatitis, defined as a doctor-diagnosis at 12, 18 
and 24 months and then yearly up to 6 years.  
Food allergy was defined as doctor-diagnosis up to 6 years of age, with point prevalences reported in 
the questionnaires at 12, 18 and 24 months and then yearly up to 6 years, except at 4 years. 
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Asthma was defined as doctor-diagnosis or at least 2 doctor-diagnosed episodes of obstructive 
bronchitis in the last 12 months in the year 4, 5 or 6 questionnaires, independently of diagnosis 
reported in the first 3 years.  
Allergic rhinitis was defined as doctor-diagnosis or presence of symptoms (itchy, runny or blocked 
nose, without a cold, and associated with red itchy eyes) between year 5 and 6, reported in the 6-year 
questionnaire. 
Atopic sensitization at the age of 1, 4.5 and 6 years was defined as positive specific IgE antibodies 
(cut-off 0.35 kU/L and 0.7 kU/L) against seasonal allergens (alder, birch, hazel, grass, rye, mugwort, 
Alternaria), perennial allergens (Dermatophagoides pteronyssinus, Dermatophagoides farinae, cat, 
horse, dog) and food allergens (hen’s egg, cow’s milk, peanut, hazelnut, carrot, plantain, wheat). 
Data on potential confounders was obtained from the questionnaires in the third trimester of 
pregnancy and when the child was 2 and 12 months old. Parental history of allergies was defined as 
self-reported asthma, allergic rhinitis and/or atopic dermatitis. According to the UNESCO 
International Standard Classification of Education (ISCED) 2011, we defined a low education level as 
ISCED levels 0 & 1, a mid level as ISCED level 2 and a high level of education as ISCED levels 3-8. 
Presence of infections was recorded in weekly diaries, in particular occurrence of rhinitis (common 
cold or runny nose), fever (at least 38.5°C), otitis, pneumonia, cough or wheeze for at least 2 of the 
last 7 days, in a given week between week 8 and 53 of life.11 
 
Statistical Analysis 
Data analysis was conducted by using IBM SPSS Statistics Version 23 (IBM Corp., Armonk, NY, 
USA). Differences in patient characteristics between exposed and unexposed were analysed by using 
Pearson’s chi-square test and expressed as p-values. Logistic regressions were used to investigate the 
association between exposure to antibiotics during pregnancy & infancy and the development of 
allergic diseases and atopy. From these analyses, odds ratios (OR) with 95% confidence intervals (CI) 
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were reported. Two models were used to evaluate the association between antibiotic exposure and 
allergy. Model 1 shows the crude results and model 2 was additionally adjusted for potential 
confounders. To consider reverse causation with postnatal exposure, we used a third model: From 
model 2, we additionally excluded children with the respective allergic disease in the first year of life 
with the exception of asthma where we excluded all cases with wheeze in the first
 
year of life.  
For this analysis the statistical significance level was defined by a p-value < 0.05. 
 
Ethical approval  
The research protocol was approved by the local research ethics committees of each study centre. 
Moreover, written informed consent was obtained from the parents.   
 
Results  
Patient characteristics 
288 (26.7%) of the overall 1080 children, who were included in the analysis for prenatal antibiotics, 
were exposed in utero (Table I). For postnatal exposure, we included 1019 children of whom 419 
children (41.1%) received antibiotics in the first
 
year of life. 136 of these 419 children were also 
exposed in utero.  
The percentage of smoking mothers was almost twice as high in the group who received antibiotics 
during pregnancy compared to mothers who were not exposed. Furthermore, a significant relationship 
between maternal education and antibiotic exposure was observed, with women in the higher 
educated group being exposed more frequently whereas women with a mid level of education 
received fewer antibiotics. Children who received antibiotics in the first year of life were less likely to 
be born by caesarean section, more likely to have siblings and tended to be breastfed during a shorter 
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period of time compared to the unexposed group. No major difference regarding antibiotic use was 
observed between farmers and non-farmers.   
Children exposed to prenatal antibiotics had a significantly higher cumulative prevalence of atopic 
dermatitis (39.9% vs. 29.8%) and food allergy (13.2% vs. 7.7%) in the first 6 years of life compared 
to non-exposed. For antibiotic intake in the first year of life, a significantly higher prevalence of 
atopic dermatitis up to 6 years of life (44.6% vs. 23.9%) was observed. 
 
Prenatal antibiotics and allergic diseases & atopy 
Associations between prenatal antibiotic exposure and doctor-diagnosis of atopic dermatitis & food 
allergy according to time of onset are presented in Table II. The analysis showed that children who 
were exposed to antibiotics in utero were significantly more likely to develop atopic dermatitis in the 
first year of life. A positive trend between exposure and atopic dermatitis was found for the later point 
prevalences up to 5 years. This analysis was further stratified for parental atopy, and no significant 
difference between the two groups could be seen (p-value for the interaction term = 0.67).  
The association reached a positive statistical significance for diagnosis of food allergy in the first year 
and between year 3 and 5.  
 
We categorized the children into four subgroups in order to study the two diseases separately: 
children who were diagnosed with both food allergy and atopic dermatitis up to 5 years of age, 
children only suffering from atopic dermatitis, children only having food allergy and children without 
either allergic disease as reference. The risk of developing both was significantly higher after 
maternal intake of antibiotics during pregnancy, with a 2.6-fold increase (Table III). We also found a 
positive trend for the development of only atopic dermatitis. However, no association was seen with 
only food allergy (small number of cases in this subgroup).  
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A significant increased risk of becoming sensitized to any allergen at the age of 4 years, especially to 
seasonal and food allergens, was observed after prenatal exposure (see Supplementary Table E1), 
with a remaining positive tendency when using a higher cut-off (0.7kU/L). No significant associations 
were found for sensitization at the age of 1 and 6 years (Supplementary Table E2). 
No association was found between exposure to antibiotics in utero and the prevalence of asthma (aOR 
1.19, 95% CI 0.69-2.05) between year 3 & 6 or current allergic rhinitis (aOR 1.18, 95% CI 0.64-2.19) 
at 6 years of age.  
 
Antibiotics in the first year of life and allergic diseases & atopy  
Antibiotics in the first year of life increased the risk of atopic dermatitis for the different time points 
up to the age of 4 years (Table IV). After exclusion of children with atopic dermatitis in the first year 
of life, we still observed a significant increased risk. Stratification for wheeze in the first year of life 
showed similar results between the two groups (p-value for the interaction term = 0.82). Additionally, 
adjusting for infections (cough, wheeze, rhinitis, otitis, fever, pneumonia) in the first year of life had 
no major impact on this association (data not shown). When we looked separately at the type of 
indication (bronchitis/pneumonia vs. other indication) no major difference between the two groups 
was detected (see Supplementary Table E3). A strong dose-response relationship was observed for the 
number of antibiotic courses (prescribed for pneumonia/bronchitis) on the cumulative prevalence of 
atopic dermatitis up to 4 years (Figure I). 
 
A borderline significant association was found for children with antibiotic intake in the first year of 
life and asthma between the age of 3 & 6 years (Table IV). This risk was higher for antibiotics 
prescribed for bronchitis or pneumonia compared to other indications and also for an increasing 
number of antibiotic courses (p-value for trend = 0.028). The association weakened after additionally 
adjusting for infections (aOR 1.41, 95% CI 0.74-2.68).  
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With regards to antibiotic intake in the first year of life, we did not find a significantly increased risk 
for food allergy (aOR 1.33, 95% CI 0.76-2.33) up to 6 years, allergic rhinitis (aOR 0.58, 95% CI 0.31-
1.10) or sensitization (aOR 1.04, 95% CI 0.73-1.47) at the age of 6.  
 
In table V we analysed four antibiotics’ exposure categories: children exposed both in utero and in the 
first year, only exposed in utero or only in the first year and never exposed as reference. The highest 
risk of atopic dermatitis up to 6 years or asthma between 3 & 6 years was seen with a cumulative 
exposure to antibiotics in utero as well as in the first year of life. 
 
Discussion  
Our results show that exposure to prenatal antibiotics is positively associated with atopic dermatitis 
and food allergy in childhood with the strongest effect on disease developing in the first year of life. 
No associations were found between prenatal antibiotic exposure and asthma or allergic rhinitis.  
A strong dose-response relationship with the number of antibiotic courses in the first year of life was 
observed on atopic dermatitis up to 4 years. Children who were exposed to three or more courses 
during the first year of life have been associated with a 7-fold increased risk to develop atopic 
dermatitis. A tendency of a positive association between antibiotic intake in the first year of life and 
asthma between 3 & 6 years was observed, but only with antibiotics prescribed for bronchitis or 
pneumonia. No significant associations were found between antibiotic exposure in the first year of life 
and food allergy, sensitization and allergic rhinitis.  
 
Similar to our results, several studies found significant positive associations between atopic dermatitis 
and antibiotic exposure in utero 12,13 or in the first year of life14-16. In contrast, the study by Bisgaard et 
al.17, where in contrast to our study only children of mothers with history of asthma were included, 
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did not see an increased risk for atopic dermatitis after maternal use of antibiotics in pregnancy. Dom 
et al. 13, who defined atopic dermatitis as parent-reported symptoms, did not find a relationship with 
antibiotics in the first year of life.  
Most studies 5,12,14,16,18-21, which have been carried out on antibiotic use during pregnancy & infancy, 
found an increased risk for asthma whereas our results only provide evidence for a weak positive 
association after antibiotic use in the first year of life but not with prenatal exposure.  Discrepancies in 
these findings might be explained by different outcome definitions. We used asthma diagnosis 
between 3 & 6 years whereas other studies on prenatal antibiotics frequently used asthma diagnosis 
starting from birth. Moreover, most significant positive results for postnatal antibiotics tended to 
come from retrospective or database studies, which are susceptible to recall biases and confounding 
by indication, what we observed in our results.5  
To our knowledge only one study has so far analysed the association between prenatal antibiotics and 
food allergy.22 In contrast to our results, they did not find a relationship between maternal antibiotics 
and food allergy, which might be explained as they only included a small number of children who 
were exposed and developed food allergy.  
 
It is well known that atopic dermatitis and food allergy are closely related.23,24 Here, we showed that 
prenatal exposure to antibiotics is strongly associated with an increased risk of developing both, 
atopic dermatitis and food allergy.  
Major strengths of our study are the large study population and prospective design, which allow 
studying the timing of exposures with occurrence before the development of allergic diseases and 
taking into account major confounding factors.  
One limitation of this study is that the study population was selected from rural areas of Europe, so 
the results might not be representative for urban areas as well as non-European countries. Another 
limitation is the small case numbers for some of the models (especially for food allergy). Even though 
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reverse causation is unlikely in the analysis of prenatal antibiotics, it is a major concern when looking 
at postnatal exposure to antibiotics. We carefully tried to take this into account by using a third model, 
where we excluded children who already had been diagnosed or had symptoms of the respective 
disease in the first year of life. Even though it helps to reduce reverse causation, this effect can still 
not completely be excluded. We observed a strong positive association between exposure to postnatal 
antibiotics for other indications than bronchitis/pneumonia and atopic dermatitis, which further 
provided evidence that not the whole effect can be due to reverse causation. The results found for 
asthma may be explained by confounding by indication as the only real association was found for 
respiratory tract infections. 
Apart from allergic rhinitis, we only included doctor-diagnosed cases in our study. This might result 
in an underestimation of the prevalence of the respective allergic disease (with the exception of food 
allergy) but reduces detection bias. Moreover, this misclassification of the outcome is most likely 
independent of the exposure (non-differential misclassification) and might lead to an underestimation 
of the OR. Regarding food allergy, the prevalence might be overestimated, as an oral food challenge 
should be carried out to make an appropriate diagnosis. A dilution effect would be induced by an 
overestimation of the prevalence and would shift the OR towards 1 (no effect). Furthermore, we do 
not expect misclassification of the exposures here. 
 
Maternal infections during pregnancy like chorioamnionitis have been associated with an increased 
risk of childhood asthma.12,25,26 It was suggested that the association between prenatal exposure to 
antibiotics and asthma is caused by other mechanisms like a heritable predisposition to infections 
rather than representing a causal link.20 Our results support this statement as adjusting for infections in 
the first year of life did weaken the association between postnatal exposure and asthma. However, the 
positive association between antibiotic exposure in the first year of life and atopic dermatitis remained 
significant independent of infections in the first year.  
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The mechanism underlying the suggested increased risk for allergies due to antibiotic exposures 
remains unclear. One potential mechanism might be the influence of antibiotic treatment on 
microbiota, as several studies have found an association between gut microbiota composition and 
allergic disease.27,28,29 Furthermore, Yassour et al.30 found that antibiotic treatment in early life 
reduces microbial diversity at 3 years.  
 
In summary, our results show positive associations between exposure to antibiotics and allergic 
diseases, mainly with atopic dermatitis and food allergy in the first year of life after prenatal exposure, 
and atopic dermatitis and asthma after postnatal exposure to antibiotics in children born in rural 
settings. Keeping this and the increasing microbial resistance in mind, appropriate prescription of 
antibiotics is all the more important.  
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Tables  
 
Table I. Patient characteristics and prevalence of atopy and allergic diseases in relation to antibiotic exposure in 
utero or first year of life 
               
 
Overall 
study 
population  
 
Antibiotics during pregnancy 
 
Antibiotics in 1
st
 year of life 
  
No 
(n=792) 
Yes 
(n=288)   
No 
(n=600) 
Yes 
(n=419) 
  
  N %   N % N % p-value* 
 
N  % N % p-value* 
Farmer        0.949      0.879 
 Yes 530 46.8  373 47.1 135 46.9   285 47.5 197 47.0  
 No 603 53.2  419 52.9 153 53.1   315 52.5 222 53.0  
Sex        0.411       0.036 
 Female 530 48.6   389 49.1 130 46.3   310 51.7 188 45.0  
 Male 560 51.4  403 50.9 151 53.7   290 48.3 230 55.0  
Parental history of atopic disease        0.074      0.735 
 Yes  595 54.1  405 51.7 165 57.9   327 54.7 223 53.6  
 No 504 45.9  378 48.3 120 42.1   271 54.3 193 46.4  
Siblings               0.280           0.006 
 0 413 36.5   298 37.6 94 32.6    239 39.8 128 30.5  
 
1-2 604 53.3   411 51.9 163 56.6     300 50.0 245 58.5   
 
3-4 98 8.6   72 9.1 24 8.3   
 
48 8.0 42 10.0 
 
 
5+ 18 1.6   11 1.4 7 2.4     13 2.2 4 1.0   
Maternal education        0.022      <0.001 
 
Low 202 17.8 
 
142 17.9 47 16.3 
  
101 16.8 69 16.5 
 
 
Mid 487 43.0   357 45.1 108 37.5     289 48.2 152 36.3   
 
High 444 39.2 
 
293 37.0 133 46.2 
  
210 35.0 198 47.3 
 
Caesarean section        0.422      0.024 
 Yes 192 17.7  136 17.3 54 19.4   119 20.0 60 14.5  
 No 890 82.3   651 82.7 224 80.6   477 80.0 355 85.5  
Pets (cats & dogs) in the 1
st
 year of life        0.983       0.149 
 Yes 598 57.2   436 57.1 152 57.1   356 59.3 229 54.8  
 No 447 42.8   328 42.9 114 42.9   244 40.7 189 45.2  
Pets (cats & dogs) during pregnancy        0.579      0.311 
 Yes 663 58.6  462 58.3 162 56.4   355 59.2 234 56.0  
 No 469 41.4   330 41.7 125 43.6   245 40.8 184 44.0  
Breastfeeding               0.493           <0.001 
 
Never  100 9.6 
 
71 9.3 29 10.9 
  
42 7.0 57 13.6 
 
 
>0 - 2 months  170 16.3   122 16.0 48 18.0     76 12.7 87 20.8   
 
3 - 6 months 289 27.7 
 
202 26.5 78 29.3 
  
158 26.4 122 29.2 
 
 
7 - 9 months  221 21.2   169 22.1 51 19.2     139 23.2 76 18.2   
 
10+ months 264 25.3 
 
199 26.1 60 22.6 
  
184 30.7 76 18.2 
 
Maternal smoking during pregnancy        <0.001       0.167 
 Yes 158 13.9   89 11.2 61 21.2   71 11.8 62 14.8  
 No 975 86.1   703 88.8 227 78.8   529 88.2 357 85.2  
Centre 
       
<0.001 
     
<0.001 
 
Austria 220 19.4   174 22.0 40 13.9     122 20.3 76 18.1   
 
Switzerland 242 21.4 
 
189 23.9 43 14.9 
  
173 28.8 46 11.0 
 
 
France 203 17.9   123 15.5 71 24.7     45 7.5 130 31.0   
 
Germany 254 22.4 
 
198 25.0 47 16.3 
  
172 28.7 53 12.6 
 
 
Finland 214 18.9   108 13.6 87 30.2     88 14.7 114 27.2   
                              
Prevalence allergic diseases 
    
          Atopic dermatitis up to 6 years         0.005       <0.001 
 Yes 288 32.7   192 29.8 89 39.9   121 23.9 154 44.6  
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 No 593 67.3   452 70.2 134 60.1   385 76.1 191 55.4  
Food allergy up to 6 years        0.016       0.081 
 Yes 80 9.2   49 7.7 29 13.2   38 7.5 37 11.0  
 No 788 90.8   585 92.3 191 86.8   468 92.5 299 89.0  
Asthma between 3 & 6 years 
       
0.417   
    
0.106 
 Yes 79 8.9  55 8.5 23 10.3   38 7.4 35 10.6  
 No 804 91.1  591 91.5 200 89.7   477 92.6 296 89.4  
Any sensitization at 1 year (cut-off: 0.35 kU/L)         0.589       0.199 
 Yes 264 28.1   187 27.7 73 29.6   137 26.3 115 30.2  
 No 675 71.9  487 72.3 174 70.4   384 73.7 266 69.8  
Any sensitization at 6 years (cut-off: 0.35 kU/L)         0.724       0.777 
 Yes 401 53.8   283 53.5 111 55.0   221 53.5 167 54.6  
 No 344 46.2   246 46.5 91 45.0   192 46.5 139 45.4  
Allergic rhinitis at 6 years 
  
  
    
0.392   
    
0.453 
 Yes 60 6.4  40 5.9 18 7.5   38 7.1 21 5.8  
 No 873 93.6  637 94.1 223 92.5   497 92.9 339 94.2  
*Based on the chi-square test 
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Table II. Association between prenatal exposure to antibiotics and doctor-diagnosis of atopic dermatitis & food allergy at different time 
points up to 6 years of age 
  
Atopic Dermatitis  
 
Food Allergy  
 
 
Model 1: crude 
 
Model 2: adjusted
†
 
 
Model 1: crude 
 
Model 2: adjusted
†
 
  n/N OR 95% CI   aOR 95% CI   n/N OR 95% CI   aOR 95% CI 
Diagnosis in the first year of life 148 
      
24 
     
  Prenatal exposure to antibiotics: yes 52/260 1.72 1.19-2.50 
 
1.66 1.11-2.48 
 
13/265 3.53 1.56-7.98 
 
3.01 1.22-7.47 
  
Prenatal exposure to antibiotics: no, 
reference 
96/757 1.00 
  
1.00 
  
11/764 1.00 
  
1.00 
 
Diagnosis between 1&1.5 years 79 
      
32 
     
 
Prenatal exposure to antibiotics: yes 24/243 1.35 0.82-2.23 
 
1.26 0.73-2.18 
 
10/246 1.38 0.64-2.95 
 
na§ na§ 
 
Prenatal exposure to antibiotics: no, 
reference 
55/732 1.00 
  
1.00 
  
22/738 1.00 
  
1.00 
 
Diagnosis between 1.5&2 years 74 
      
24 
     
  Prenatal exposure to antibiotics: yes 23/250 1.37 0.82-2.29 
 
1.26 0.73-2.19 
 
9/252 1.80 0.78-4.17 
 
2.19 0.89-5.40 
  
Prenatal exposure to antibiotics: no, 
reference 
51/740 1.00 
  
1.00 
  
15/744 1.00 
  
1.00 
 
Diagnosis between 2&3years 71 
      
21 
     
 
Prenatal exposure to antibiotics: yes 27/248 1.87 1.13-3.09 
 
1.54 0.90-2.63 
 
9/248 2.22 0.93-5.34 
 
2.28 0.89-5.83 
 
Prenatal exposure to antibiotics: no, 
reference 
44/718 1.00 
  
1.00 
  
12/720 1.00 
  
1.00 
 
Diagnosis between 3&4
‡
 years 61 
      
15 
     
  Prenatal exposure to antibiotics: yes 21/248 1.59 0.92-2.76 
 
1.43 0.80-2.56 
 
8/244 3.39 1.21-9.44 
 
3.45 1.13-10.49 
  
Prenatal exposure to antibiotics: no, 
reference 
40/729 1.00 
  
1.00 
  
7/706 1.00 
  
1.00 
 
Diagnosis between 4&5 years 45 
            
 
Prenatal exposure to antibiotics: yes 17/245 1.81 0.97-3.36 
 
1.42 0.74-2.75 
       
 
Prenatal exposure to antibiotics: no, 
reference 
28/706 1.00 
  
1.00 
        
Diagnosis between 5&6 years 19 
      
8 
     
  Prenatal exposure to antibiotics: yes 4/213 0.76 0.25-2.32 
 
0.64 0.20-2.03 
 
3/194 1.84 0.44-7.76 
 
1.53 0.33-7.20 
  
Prenatal exposure to antibiotics: no, 
reference 
15/611 1.00 
  
1.00 
  
5/590 1.00 
  
1.00 
 
Diagnosis up to 6 years  281       78      
 Prenatal exposure to antibiotics: yes 89/223 1.56 1.14-2.15  1.19 0.69-2.05  29/220 1.81 1.11-2.95  1.80 1.05-3.07 
 
Prenatal exposure to antibiotics: no, 
reference 
192/644 1.00   1.00   49/634 1.00   1.00  
† 
adjusted for farmer, centre, parental atopic status, gender, smoking during pregnancy, number of siblings, pets (dogs & cats) during pregnancy, caesarean section, maternal education  
‡
 diagnosis between 3&5 years for food allergy 
        
   § zero count for one of the centres         
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Table III. Association between prenatal exposure to antibiotics and doctor-diagnosis of atopic dermatitis and/or food 
allergy up to the age of 5 years 
 
  Sensitization at 4 years  
(Cut-off: 0.7kU/L) 
 Prenatal antibiotics (Cases=213) 
 
 
 Any 
allergen 
 
Food 
allergens 
 
Inhalant 
allergens 
 Model 1: crude 
 
Model 2: adjusted
†
 
 %  %  %  n/N OR 95% CI 
 
aOR 95% CI 
Atopic dermatitis and food allergy up to 5 years  58.8  41.2  47.1  18/40 2.90 1.51-5.56 
 
2.63 1.29-5.39 
Only atopic dermatitis up to 5 years   43.1  20.8  34.0  57/187 1.55 1.08-2.24 
 
1.41 0.95-2.09 
Only food allergy up to 5 years   56.3  37.5  31.3  5/22 1.04 0.38-2.88 
 
1.05 0.36-3.08 
No atopic dermatitis & no food allergy up to 5 
years, reference 
 
45.1  27.5  33.0  133/604 1.00   1.00  
†
adjusted for farmer, centre, parental atopic status, gender, smoking during pregnancy, number of siblings, pets (dogs & cats) during pregnancy, caesarean 
section, maternal education 
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Table IV. Association between exposure to antibiotics in the first year of life and doctor-diagnosis of 
atopic dermatitis at different time points & asthma. 
 
 
Model 1: crude 
 
Model 2: adjusted
†
 
 
Model 3: adjusted
†
 
and excluded
‡
 
  n/N OR 95% CI   aOR 95% CI  
aOR 95% CI 
Atopic dermatitis between 1&1.5 years 76 
        
  Exposure to antibiotics (1st year): yes 41/384 1.82 1.13-2.91 
 
1.66 0.96-2.88 
 
2.71 1.14-6.48 
  Exposure to antibiotics (1st year): no, reference 35/567 1.00 
  
1.00 
  
1.00 
 
Atopic dermatitis between 1.5&2 years 70 
        
  Exposure to antibiotics (1st year): yes 39/394 1.91 1.17-3.13 
 
1.99 1.14-3.50 
 
2.30 1.06-5.00 
  Exposure to antibiotics (1st year): no, reference 31/571 1.00 
  
1.00 
  
1.00 
 
Atopic dermatitis between 2&3years 66 
        
  Exposure to antibiotics (1st year): yes 39/386 2.19 1.32-3.65 
 
1.94 1.07-3.50 
 
2.58 1.13-5.91 
  Exposure to antibiotics (1st year): no, reference 27/554 1.00 
  
1.00 
  
1.00 
 
Atopic dermatitis between 3&4 years 57 
        
  Exposure to antibiotics (1st year): yes 39/387 3.40 1.91-6.04 
 
2.68 1.40-5.12 
 
4.11 1.69-10.03 
  Exposure to antibiotics (1st year): no, reference 18/564 1.00 
  
1.00 
  
1.00 
 
Atopic dermatitis between 4&5 years 40 
        
  Exposure to antibiotics (1st year): yes 24/373 2.31 1.21-4.42 
 
1.61 0.77-3.33 
 
1.85 0.71-4.82 
  Exposure to antibiotics (1st year): no, reference 16/554 1.00 
  
1.00 
  
1.00 
 
Atopic dermatitis between 5&6 years 17 
        
  Exposure to antibiotics (1st year): yes 8/309 1.44 0.55-3.77 
 
0.95 0.31-2.88 
 
1.28 0.40-4.03 
  Exposure to antibiotics (1st year): no, reference 9/496 1.00 
  
1.00 
  
1.00 
 
Atopic dermatitis up to 6 years  275         
 Exposure to antibiotics (1st year): yes 154/345 2.57 1.91-3.44  1.91 1.36-2.67  2.65 1.69-4.16 
 Exposure to antibiotics (1st year): no, reference 121/506 1.00   1.00   1.00  
           
Asthma between 3&6 years of age  73         
  Exposure to antibiotics (1
st year): yes 35/331 1.48 0.92-2.40  1.65 0.95-2.86  1.33 0.63-2.83 
  
 
 Antibiotics because of other indication than   
bronchitis/pneumonia 
18/220 0.96 0.54-1.69  1.03 0.55-1.91  0.96 0.43-2.13 
    Antibiotics because of bronchitis/pneumonia 12/89 1.68 0.85-3.30  1.85 0.86-3.99  1.32 0.34-5.15 
  Exposure to antibiotics (1
st year): no, reference 38/515 1.00   1.00   1.00  
†
adjusted for farmer, centre, parental atopic status, gender, smoking during pregnancy, number of siblings, pets (dogs & cats) during 
pregnancy or first year of life, months of breastfeeding, caesarean section  
‡ Exclusion of children with atopic dermatitis in the 1st year of life for atopic dermatitis and exclusion of children with wheeze in the 
1st year of life for asthma 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
Table V. Association between exposure to antibiotics during pregnancy & first year of life and allergic diseases & atopy 
  
Atopic dermatitis up to 6 years  
 
Asthma between 3&6 years  
 
Food allergy up to 6 years  
 
Allergic rhinitis at 6 years  
 
Any sensitization at 6 years 
(cut-off: 0.35 kU/L)  
   
Model 2: adjusted
†
 
  
Model 2: adjusted
†
 
  
Model 2: adjusted
†
 
  
Model 2: adjusted
†
 
  
Model 2: adjusted
†
 
Antibiotic exposure  n/N aOR 95% CI 
 
n/N aOR 95% CI 
 
n/N aOR 95% CI 
 
n/N aOR 95% CI 
 
n/N aOR 95% CI 
Yes  
                   
 
Pregnancy & 1st year  53/111 2.49 1.44-4.30 
 
12/109 2.32 0.96-5.60 
 
14/110 1.42 0.59-3.37 
 
6/121 0.47 0.16-1.40 
 
62/105 1.01 0.58-1.77 
 
Only pregnancy  29/102 1.23 0.73-2.09 
 
9/102 1.36 0.59-3.11 
 
13/101 2.39 1.08-5.26 
 
11/108 1.55 0.69-3.46 
 
45/88 0.97 0.58-1.61 
 
Only 1st year  97/228 1.92 1.29-2.86 
 
23/217 1.68 0.87-3.21 
 
22/220 1.47 0.73-2.98 
 
14/233 0.70 0.33-1.51 
 
102/195 1.06 0.70-1.60 
No (reference) 90/398 1.00 
  
28/407 1.00 
  
25/399 1.00 
  
26/421 1.00 
  
173/320 1.00 
 †adjusted for farmer, centre, parental atopic status, gender, smoking during pregnancy, number of siblings,  pets (dogs & cats) during pregnancy, caesarean section, maternal 
education  
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Figure legend  
Figure I. Association between atopic dermatitis up to 4 years and number of antibiotic courses 
(prescribed for pneumonia/bronchitis) in the first
 
year of life  
 
 
 
 
 
 
 
 
 
 
* adjusted for farmer, centre, parental atopic status, gender, smoking during pregnancy, 
number of siblings, pets (dogs & cats) during pregnancy or first year of life, months of 
breastfeeding, caesarean section after exclusion of children with atopic dermatitis in the 
first year of life 
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